LCLC-97TM1

Zellname

Beschreibung

Bestell-Nr.

Einheit

Preis, Euro

LCLC-97TM1

Humane Lungenkarzinom (großzellig) Zell-Linie

300409

cryovial

265,00

LCLC-97TM1

Humane Lungenkarzinom (großzellig) Zell-Linie

330409

vital

335,00



Designation:LCLC-97TM1
Depositor:CLS
Organism:Homo sapiens (human)
Ethnicity:Caucasian
Tissue:carcinoma,large cell, lung
Morphology:epithelial
Growth Properties:monolayer
Description:in vitro etablished fro the primary lung large cell carcinoma
Culture Medium:Minimum essential medium (Eagle) in Earle`s BSS with non- essential amino acids, 90%, fetal bovine serum, 10%
Subculturing:Remove medium, add fresh 0.025% trypsin, 0.02% EDTA for several minutes, remove trypsin and let the culture sit at 37°C for 5 to 10 minutes. Add fresh medium, aspirate and dispense into new flasks.
Split Ratio:A ratio of 1:2 to 1:6 is recommended
Fluid Renewal:1 to 2 times weekly
Freeze Medium:CM-1 (CLS ∙ Cell Lines Service)
Sterility:Tests for mycoplasma, bacteria and fungi were negative
Biosafety Level:1
Tumorigenic:yes, in nude mice
Reverse Transcriptase:negative


References:

Bepler G et al. Characterization of the state of six newly established human non-small-cell lung cancer cell lines. Differentiation 37(2):158-71, 1988.
Heidtmann HH et al. Synthesis and secretion of plasminogen activators and plasminogen activator inhibitors in cell lines of different groups of human lung tumors. Cancer res 49: 6960-5, 1989.
Heidtmann HH et al. Secretion of a latent, acid activable cathepsin L precursor by human non-small cell lung cancer cell lines. Oncol res 5: 441-51, 1993.
Hofmann J et al. Gucocorticoid receptors and growth inhibitory effects of dexamethasone in human lung cancer cell lines. Eur J Cancer 31A: 2053-8, 1995.
European-Journal-of-Cancer-Part-A- General-Topics. 31/12 (2053-2058), 1995

 

  Change language: eng        Diese Seite drucken   Sitemap   Kontakt  


 
top